Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Clotiazepam 5 mg Coated Tablets
NCT04440423Phase 1Completed
- Sponsor
- Laboratorios Andromaco S.A.
- Start
- Mar 2020
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of clotiazepam in anxiety disorder, sponsored by Laboratorios Andromaco S.A. Primary endpoints: Area Under the Plasma Concentration-Time Curve from 0 to 34 hours, Area Under the Plasma Concentration-Time Curve from 0 to time t at 34 hours and 1 more. Started Mar 2020; status: completed.
02
Drugs
clotiazepam
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04440423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04440423.